Integrative Peptide Drug Development: Chemical Engineering, AI-Driven Design, and Cell-Penetrating Peptides
Authors:
- Yong Eun JangYJYong Eun Jang
- Minjun KwonMKMinjun Kwon
- Chan Woo KwonCKChan Woo Kwon
- Seok Gi KimSKSeok Gi Kim
- Ji Su HwangJHJi Su Hwang
- Nimisha Pradeep GeorgeNGNimisha Pradeep George
- Seung Ryong PaikSPSeung Ryong Paik
- Sampa MisraSMSampa Misra
- Shaherin BasithSBShaherin Basith
- Seung Soo SheenSSSeung Soo Sheen
- Gwang LeeGLGwang Lee
Open Access
- 28 April 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 537
Abstract
Peptide therapeutics occupy a unique chemical space between small molecules and biologics, combining high target specificity with structural programmability and favorable safety profiles. Recent regulatory approvals and expanding clinical pipelines underscore the growing therapeutic and commercial relevance of peptide-based drugs. This review outlines chemical modification approaches and contemporary design strategies, and evaluates their impact on proteolytic stability, pharmacokinetics, membrane permeability, and target engagement. We then highlight recent advances in artificial intelligence (AI)-guided peptide drug design, including machine learning models, protein language models, and generative architectures that enable high-throughput activity prediction, property optimization, and de novo sequence generation. These approaches collectively accelerate the traditional discovery–design–validation cycle while reducing experimental attrition through data-driven, structure-informed modeling frameworks. Among these applications, AI also enables the rational design of cell-penetrating peptides (CPPs) to enhance intracellular delivery and biological activity. Building on these methodological advances, we further examine their application to peptide therapeutics, with particular emphasis on AI-based predictive models for CPPs as well as on therapeutic applications within the central nervous and pulmonary systems. We conclude by outlining future perspectives and emphasize that the systematic integration of AI-enabled sequence design with rational chemical engineering and advanced delivery technologies, supported by rigorous experimental validation, will be critical for developing robust and clinically durable peptide-based medicines.Keywords
Funding Information
- Ministry of Science and ICT, South Korea (RS-2023-NR076560)
- Ministry of Science and ICT, South Korea (RS-2024-00416536)
- Korea Medical Institute (KMI20250222)
This publication has 258 references indexed in Scilit:
- Advances in Hydrocarbon Stapled Peptides via Ring‐Closing Metathesis: Synthetic Strategies, Structural Diversity, and Therapeutic ApplicationsChemBioChem, 2025
- Structural information in therapeutic peptides: Emerging applications in biomedicineFEBS Open Bio, 2024
- Peptide‐Based Supramolecular Therapeutics for Fighting Major DiseasesAdvanced Functional Materials, 2024
- Novel Therapeutic Modalities: The Future is NowClinical Pharmacology & Therapeutics, 2023
- Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and ApplicationsChemMedChem, 2023
- Better Peptides via Chemical Glycosylation: Somatostatin Analogues Having a Human Complex‐Type N‐Glycan with Improved Drug PropertiesChemistry – A European Journal, 2023
- The role of cell‐penetrating peptides in potential anti‐cancer therapyClinical and Translational Medicine, 2022
- Cyclic Cell‐Penetrating Peptides with Single Hydrophobic GroupsChemBioChem, 2019
- Cell‐penetrating peptides: Achievements and challenges in application for cancer treatmentJournal of Biomedical Materials Research Part A, 2013
- The Ascent of Pulmonary Drug DeliveryJournal of Pharmaceutical Sciences, 2000